Notch signaling pathway mediates different biological processes including stem cell self-renewal, progenitor cell fate decisions, and terminal differentiation. TWIST1 play key roles in tumor development and metastasis through induces epithelial-mesenchymal transition (EMT). Expression of the transcription complex core Notch pathway and target genes, as well as excessive TWIST1, are closely associated with aggressive clinicopathological variables esophageal squamous cell carcinoma (ESCC). Here we aim to explain the possible functional crosstalk between TWIST1 and Notch pathways in ESCCs.
Correlation between TWIST1 and Notch target genes was analyzed in 50 ESCCs and corresponding normal tissue. Using retroviral system, forced expression TWIST1 established ESCC KYSE-30 cell line and the expression of genes Notch signaling was assessed. a significant correlation between the expression TWIST1 and HEY1 / by hey2 found in different pathological variables of ESCC poor prognosis.
TWIST1 induced expression in KYSE-30 cells led to an increase noteworthy of Notch pathway gene expression revealed TWIST1 gene regulatory role of Notch signaling in cells. Based on the existing correlation between the expression of genes TWIST1 and Notch pathway in different pathological features of patients with ESCC, and KYSE-30 cell line, we can estimate that TWIST1 involved in the aggressiveness of the disease through regulation of Notch signaling genes. To the best of knowledge, this is the first report describing the effect TWIST1 Notch cascade genes in ESCC
TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma
3-O- (E) p-Coumaroyl betulinic acid has anti-cancer activity and inhibits the Notch signaling pathway in breast cancer cells and mammosphere
Activation of Notch signaling is associated with tumor aggressiveness, poor clinical outcomes and drug resistance in breast cancer patients. Targeting Notch signaling with small molecule inhibitors may be a better strategy for anticancer drug development. We identified 3-O- (E) p-Coumaroylbetulinic acid (CB) as a lead compound and a potent inhibitor of Notch signaling pathway. Treatment of human breast cancer MBA-MD-231 and T47D cells with CB resulted in dose-and time-dependent inhibition of cell viability and G0 / G1 phase cell cycle arrest.
This effect was associated with a sharp decrease in the expression of cyclin D1 and its activating partner, cyclin-dependent kinase 2 with a concomitant increase in the cyclin kinase inhibitor p21, operating in G1 phase of the cell cycle. CB treatment induced early apoptosis of breast cancer cells as evidenced by an increase in cleaved caspase-3, a decrease in Bcl-2 and survivin, a surge of reactive oxygen species and mitochondrial membrane potential interference. CB treatment Notch target gene is altered.
Hes1, Hey1 and E-cadherin at the mRNA and protein levels in a time-dependent manner along with a decrease in Notch promoter activity at IC50 concentrations. Furthermore, treatment CB decline mammosphere formation in MCF-7 cells by down-modulation of the Notch signaling pathway and suppression of self-renewal markers such as c-Myc, SOX-2 and CD44. Our findings indicate that the CB has anticancer activity in breast cancer cells and suppress the ability of self-renewal in mammosphere as a result of modulation of cell-cycle engine, impaired mitochondrial function, induction of apoptosis, and inhibition.
Description: A competitive ELISA for quantitative measurement of Rat Agouti signaling protein(ASIP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Agouti signaling protein(ASIP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Agouti signaling protein(ASIP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Suppressors Of Cytokine Signaling 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Regulator Of G Protein Signaling 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Regulator Of G Protein Signaling 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Rat Regulator Of G Protein Signaling 4 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Inhibiting Notch Notch signaling may be an effective way to prevent retinal fibrosis , This study is of clinical significance in developing treatments to prevent fibrosis in proliferative vitreoretinopathy, proliferative diabetic retinopathy and wet age-related macular degeneration.
No Comment